Ajanta Pharma Ltd. - Research Center
532331 AJANTPHARM Group (A) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sales |
2,206.18 |
1,959.76 |
1,687.52 |
1,574.21 |
1,566.43 |
Operating profit |
618.74 |
557.52 |
347.04 |
425.02 |
465.87 |
Interest |
1.45 |
3.02 |
1.34 |
7.88 |
1.24 |
Gross profit |
686.00 |
631.15 |
459.49 |
473.46 |
548.04 |
EPS (Rs) |
37.58 |
33.59 |
24.70 |
38.39 |
44.89 |
Half yearly
results in details
|
Sep ' 24 |
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Other income |
68.71 |
76.65 |
113.79 |
56.32 |
83.41 |
Stock adjustment |
-7.48 |
6.24 |
30.19 |
-67.65 |
11.05 |
Raw material |
445.50 |
441.36 |
400.46 |
415.62 |
357.42 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
507.33 |
401.78 |
337.82 |
294.01 |
291.86 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
642.09 |
552.86 |
572.01 |
507.21 |
440.23 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
66.24 |
65.28 |
62.55 |
60.80 |
60.16 |
Taxation |
148.75 |
141.47 |
79.39 |
83.11 |
97.57 |
Net profit / loss |
471.01 |
424.40 |
317.55 |
329.55 |
390.31 |
Extra ordinary item |
- |
- |
- |
- |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
25.07 |
25.27 |
25.71 |
17.17 |
17.39 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
28.05 |
28.45 |
20.57 |
27.00 |
29.74 |
GPM (%) |
30.16 |
30.99 |
25.51 |
29.04 |
33.22 |
NPM (%) |
20.70 |
20.84 |
17.63 |
20.21 |
23.66 |